Related Experiment Video
Updated: May 5, 2026
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Lung cancer screening
1Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract:
The National Lung Screening Trial demonstrated that lung cancer screening with three annual low-dose computed tomographic scans has the potential to reduce lung cancer-specific mortality by 20% in an older population of heavy smokers. This was a great achievement by the National Lung Screening Trial (NLST) investigators, but this should be viewed as an important first step in an unfinished process. Many major questions remain about how to best realize this mortality reduction in a practical real-world context. Screening for lung cancer will be most effective if it is accompanied by continued research into risk modeling, patient communication strategies, and biomarkers. For clinicians establishing a program of lung cancer screening, we encourage this to be done in a responsible fashion, adhering to practices specified in the design of the NLST, and with careful attention given to proper management of screen-detected abnormalities and maintenance of screening registries.
Insights
Lung cancer screening using low-dose CT scans can reduce mortality by 20% in heavy smokers. Further research is needed to optimize screening effectiveness in real-world settings.
Area of Science:
- Oncology
- Radiology
- Public Health
Background:
- The National Lung Screening Trial (NLST) showed low-dose computed tomography (LDCT) screening reduces lung cancer mortality by 20% in high-risk individuals.
- This landmark study provides a foundation for lung cancer screening programs.
Purpose of the Study:
- To discuss the implications of the NLST findings.
- To highlight areas for future research and considerations for implementing lung cancer screening programs.
Main Methods:
- The abstract discusses the findings of the National Lung Screening Trial (NLST).
- It emphasizes the need for continued research and responsible implementation of screening programs.
Main Results:
- Lung cancer screening with LDCT demonstrated a 20% reduction in lung cancer-specific mortality in a population of heavy smokers.
- The NLST results represent a significant advancement but require further investigation for practical application.
Conclusions:
- Lung cancer screening is a crucial first step, but ongoing research in risk modeling, patient communication, and biomarkers is essential.
- Clinicians should implement screening responsibly, following NLST guidelines, managing abnormalities, and maintaining registries.
Related Concept Videos
02:59Cancer Prevention
02:59Cancer Prevention
Some...
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...